Alpine Associates Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,219,200
| Closed | -$224M | – | 69 |
|
|
2021
Q2 | $224M | Buy |
1,219,200
+173,500
| +17% | +$31.9M | 6.15% | 4 |
|
|
2021
Q1 | $160M | Buy |
1,045,700
+557,100
| +114% | +$85.2M | 4.34% | 9 |
|
|
2020
Q4 | $76.3M | Buy |
+488,600
| New | +$76.3M | 3.12% | 13 |
|
|
2015
Q3 | – | Sell |
-143
| Closed | -$26K | – | 62 |
|
|
2015
Q2 | $26K | Buy |
+143
| New | +$26K | ﹤0.01% | 65 |
|